What We Do
Cardihab™ is a digital health company that exists to help patients reach optimal health when at risk of, or living with, heart disease.
Our scientifically validated Digital Cardiac Rehabilitation (DCR) solution uses smartphone apps and web portals to give clinicians the ability to deliver more convenient, flexible and engaging cardiac rehabilitation services to patients.
Our solution has been demonstrated to increase cardiac rehabilitation uptake, adherence and completion rates, which means better outcomes for patients, clinicians and health service administrators.
Cardihab Pty Ltd is a spinoff company from Australia’s leading publicly funded science organisation, the Commonwealth Science & industrial Research Organisation (CSIRO).
Cardihab was incorporated in February 2016 as the commercialisation vehicle for mobile health (m-health) research at the Australian E-Health Research Centre (AEHRC) - a joint venture between CSIRO and Queensland Health.
Cardihab completed the CSIRO ON and HCF Catalyst accelerator programs and its shareholders include Artesian Capital Management, Uniseed and CSIRO (on behalf of AEHRC).
The Cardihab Team
Helen Souris - Chief Executive Officer
Helen has a BA in Statistics and Computer Science with 20+ years of commercial expertise in FMCG, digital innovation, MedTech and BioTech. As our CEO, Helen’s focus is to deliver innovative solutions that leverage the capabilities of technology and data to improve outcomes for patients and healthcare professionals. She is a strong advocate for evidence-based digital health innovations that support the growth of the Australian digital health ecosystem.
Christine Kwong - Clinical Integration & Customer Support
Christine is a Clinical Nurse with experience in cardiac nursing such as Coronary Care, Cardiac Catheter Lab and 10 years as a Cardiac Rehabilitation Nurse. As our Clinical Integration & Customer Support Specialist, Christine is responsible for ensuring the design of our care plans are both aligned with clinical guidelines and clinical practice. She is also responsible for ensuring that our customers are supported as they integrate our platform into their models of care.
Grant Jennings - Senior Technical Lead
Grant has a double Bachelor degrees in Engineering and IT and has more than 20 years’ experience in software architecture and development internationally. As our Tech Lead, Grant is responsible for the technical direction and delivery of our service offering.
Claire Cottrell - Clinical Outcomes & Market Access
Claire has a BSc and MSc with 15 years experience in the Med Tech Industry working both in Europe and across APAC in Sales, Marketing and Business Development. Prior to joining industry she began her clinical career as a Cardiac Physiologist initially at The Prince Charles Hospital Brisbane before moving to the UK and eventually joining the NHS. She has a passion for leveraging clinical evidence and digital technologies to expand access and improve patient outcomes.
Mark Roland - Engineer
Mark has a BS in Electronics Engineering from Mapua Institute of Technology. As our Mobile app Engineer, Mark is responsible for the iOS and Android apps that our patients use throughout their cardiac rehabilitation program and beyond.
Ezsa Franza - Quality Assurance
Ezsa has a Bachelor’s degree in Information Technology from the University of Perpetual Help System Dalta. As our QA Engineer, Ezsa is responsible for Cardihab’s Quality Assurance framework and also provides customer support for Australia and New Zealand.
Loyd Ocampo - Engineer
Loyd has a BE in Electrical Engineering from the University of New South Wales and has a decade of technical and leadership experience in software development in the military and private sector. He specializes in cyber security, network and systems architecture, mobile apps and API development.
Board of Directors
Dr John Rivers
Dr John Rivers is a practising cardiologist and founding member of the Queensland Cardiovascular Group.
John has extensive experience in business development and governance in the healthcare industry. He has a long term interest in medical quality systems, particularly clinician driven systems for measuring and improving patient outcomes, including the interface with clinical governance. He is a previous board member and Commissioner of the Health Quality and Complaints Commission of Queensland.
John is an active member of the Brisbane Angels group.
Natasha Rawlings - Chair
Natasha Rawlings is an Investment Manger at Uniseed – an early stage commercialisation fund supported by four outstanding Australian universities and CSIRO. Before joining Uniseed, Natasha was a tech entrepreneur who led, founded and mentored early and mid-stage tech start-ups, with a particular focus on creating revenue through sales and marketing.
Before startups, Natasha had a successful career as a marketer holding top management positions in Australian and UK companies including Marketing Director of International Masters Publishers (publishing), Guthy-Renker (cosmetics and fitness), and was a Senior Manager in corporate innovation/ new revenue streams at News Corporation in the UK.
Natasha holds a Bachelor of Business from the University of Technology, Sydney.
Madeline is part of the Commercialisation Team at Australia's national science agency, the CSIRO.
She has over 20 years experience in the life sciences sector including extensive commercialisation experience, helping many entrepreneurs and researchers to identify and commercialise their intellectual property, and facilitating early-stage innovators develop their businesses.
Prior to CSIRO she held senior-level positions overseas at MNCs and at a major University in Hong Kong where she nurtured her passion and honed her skills for the commercialisation of research into products and services that benefit society.
Madeline obtained her PhD (Med) from the University of Sydney, Australia.
Andrew has deep experience in the Medtech and Pharma industries spanning close to 30 years across a variety of roles and functions including General Management, Market Access, Public Affairs, & Policy in Australia, New Zealand and in the Asia Pacific region. Over the last ten years he has been responsible for Market Access Strategy, Leading Government, Industry and Key Stakeholder Relations and developing policy positions around access to health technology and therapies.